Abstract
Positron emission tomography (PET) studies of typical neuroleptics suggest that 60% to 80% of striatal D2 occupancy may be sufficient for optimal clinical treatment of psychosis. Therefore, striatal D2 occupancy may be used as an index to determine the optimal dose range. Toward this end, we determined the in vivo D2 profile of loxapine, using [11C]-raclopride and PET. Seven patients selected from a clinical population were scanned while taking steady-state oral loxapine from 10 to 100 mg/day. Their D2 receptor occupancy was estimated by comparing them to age-matched data from neuroleptic-naive patients. The D2 receptor occupancy ranged from 52% to 90%, and there was a very strong relationship between dose and D2 occupancy, suggesting that 15 to 30 mg/day of loxapine would produce, the putatively optimal, 60% to 80% striatal D2 blockade. This dose range is much lower than that used in most clinical settings and points to the potential efficacy of loxapine at lower doses. © American College of Neuropsychopharmacology
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kapur, S., Zipursky, R., Jones, C. et al. The D2 Receptor Occupancy Profile of Loxapine Determined Using PET. Neuropsychopharmacol 15, 562–566 (1996). https://doi.org/10.1016/S0893-133X(96)00100-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S0893-133X(96)00100-5
Keywords
This article is cited by
-
Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study
Psychopharmacology (2013)
-
D2 Receptor Occupancy of Olanzapine Pamoate Depot Using Positron Emission Tomography: An Open-label Study in Patients with Schizophrenia
Neuropsychopharmacology (2008)
-
First- and second-generation antipsychotic medication and cognitive processing in schizophrenia
Current Psychiatry Reports (2005)
-
A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)
Psychopharmacology (2005)
-
A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens
Psychopharmacology (2003)